LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.59). Revenue for the quarter came in at $12.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.